{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:11:03Z","timestamp":1770487863372,"version":"3.49.0"},"reference-count":83,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>The aim of the present study was to develop novel Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG)-loaded polymeric microparticles with optimized particle surface characteristics and biocompatibility, so that whole live attenuated bacteria could be further used for pre-exposure vaccination against Mycobacterium tuberculosis by the intranasal route. BCG was encapsulated in chitosan and alginate microparticles through three different polyionic complexation methods by high speed stirring. For comparison purposes, similar formulations were prepared with high shear homogenization and sonication. Additional optimization studies were conducted with polymers of different quality specifications in a wide range of pH values, and with three different cryoprotectors. Particle morphology, size distribution, encapsulation efficiency, surface charge, physicochemical properties and biocompatibility were assessed. Particles exhibited a micrometer size and a spherical morphology. Chitosan addition to BCG shifted the bacilli surface charge from negative zeta potential values to strongly positive ones. Chitosan of low molecular weight produced particle suspensions of lower size distribution and higher stability, allowing efficient BCG encapsulation and biocompatibility. Particle formulation consistency was improved when the availability of functional groups from alginate and chitosan was close to stoichiometric proportion. Thus, the herein described microparticulate system constitutes a promising strategy to deliver BCG vaccine by the intranasal route.<\/jats:p>","DOI":"10.3390\/md14050090","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T04:38:53Z","timestamp":1462941533000},"page":"90","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Effect of Experimental Parameters on Alginate\/Chitosan Microparticles for BCG Encapsulation"],"prefix":"10.3390","volume":"14","author":[{"given":"Liliana","family":"Caetano","sequence":"first","affiliation":[{"name":"ESTeSL-Lisbon School of Health Technology, Polytechnic Institute of Lisbon, 1990-096 Lisbon, Portugal"},{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal"}]},{"given":"Ant\u00f3nio","family":"Almeida","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-2740","authenticated-orcid":false,"given":"L\u00eddia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1920","article-title":"Envisioning future strategies for vaccination against tuberculosis","volume":"6","author":"Kaufmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2010.09.015","article-title":"Future vaccination strategies against tuberculosis: Thinking outside the box","volume":"33","author":"Kaufmann","year":"2010","journal-title":"Immunity"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-007-9084-0","article-title":"Host innate immune response to Mycobacterium tuberculosis","volume":"27","author":"Bhatt","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.4049\/jimmunol.178.6.3721","article-title":"Synergistic effect of bacillus Calmette Guerin and a Tuberculosis subunit vaccine in cationic liposomes: Increased immunogenicity and protection","volume":"178","author":"Dietrich","year":"2007","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/j.vaccine.2007.03.039","article-title":"Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB\/c mice","volume":"25","author":"Ajdary","year":"2007","journal-title":"Vaccine"},{"key":"ref_9","unstructured":"Almeida, A.J., and Alpar, H.O. (1997). Antigen Delivery Systems\u2014Imunological and Technical Issues, Harwood Academic Publishers."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(97)00249-1","article-title":"Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.addr.2004.09.004","article-title":"Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery","volume":"57","author":"Alpar","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2006.03.047","article-title":"Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN","volume":"319","author":"Tafaghodi","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2010.06.009","article-title":"Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination","volume":"148","author":"Jiskoot","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4161\/hv.4.4.5742","article-title":"Improving vaccine delivery using novel adjuvant systems","volume":"4","author":"Pichichero","year":"2008","journal-title":"Hum. Vaccin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejps.2011.10.003","article-title":"Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in mice","volume":"45","author":"Bal","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jconrel.2005.10.010","article-title":"Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency","volume":"110","author":"Kazzaz","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1166\/jbn.2014.1984","article-title":"Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: A review","volume":"10","author":"Caetano","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0168-3659(01)00412-6","article-title":"Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?","volume":"76","author":"Thiele","year":"2001","journal-title":"J. Control. Release"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1163\/1568562052843339","article-title":"Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier","volume":"16","author":"Douglas","year":"2005","journal-title":"J. Biomater. Sci. Polym."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/02652048.2011.569763","article-title":"The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers","volume":"28","author":"Grabnar","year":"2011","journal-title":"J. Microencapsul."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1016\/j.vaccine.2012.08.050","article-title":"Intranasal immunization of mice against Streptococcus equi using positively charged nanoparticulate carrier systems","volume":"30","author":"Figueiredo","year":"2012","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biomaterials.2008.10.035","article-title":"The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles","volume":"30","author":"Florindo","year":"2009","journal-title":"Biomaterials"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10611869509015939","article-title":"Aspects of the design and delivery of microparticles for vaccine applications","volume":"3","author":"Jenkins","year":"1995","journal-title":"J. Drug Target."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-409X(01)00167-3","article-title":"Microparticles for intranasal immunization","volume":"51","author":"Vajdy","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/10611869609015965","article-title":"Nasal delivery of vaccines","volume":"3","author":"Almeida","year":"1996","journal-title":"J. Drug Target."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2011.09.018","article-title":"Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles","volume":"45","author":"Cadete","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Figueiredo, L., Calado, C.C.R., Almeida, A.J., and Gon\u00e7alves, L.M.D. (2012, January 23\u201325). Protein and DNA nanoparticulate multiantigenic vaccines against H. pylori: In vivo evaluation. Proceedings of the 2012 IEEE 2nd Portuguese Meeting in BioEngineering, Coimbra, Portugal. IEEE EMBS Portuguese Chapter, I.I.","DOI":"10.1109\/ENBENG.2012.6331366"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1023\/A:1012128907225","article-title":"Chitosan and Chitosan-Ethylene Oxide-Propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines","volume":"14","author":"Calvo","year":"1997","journal-title":"Pharm. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1166\/jnn.2007.609","article-title":"Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation","volume":"7","author":"Sarmento","year":"2007","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4","article-title":"Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers","volume":"63","author":"Calvo","year":"1997","journal-title":"J. Appl. Polym. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2006.02.008","article-title":"Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies","volume":"66","author":"Sarmento","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sarmento, B. (2012). Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting, and Polymer Therapeutics, John Wiley & Sons, Ltd.","DOI":"10.1002\/9781119962977"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1081\/DDC-120003853","article-title":"Alginate in drug delivery systems","volume":"28","author":"Karlsen","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(03)00098-1","article-title":"Polymer relationships during preparation of chitosan\u2013alginate and poly-l-lysine\u2013alginate nanospheres","volume":"89","author":"De","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(99)00030-7","article-title":"Effect of chitosan on epithelial permeability and structure","volume":"182","author":"Dodane","year":"1999","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.addr.2009.11.009","article-title":"Chitosan-based delivery systems for protein therapeutics and antigens","volume":"62","author":"Amidi","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1208\/s12248-009-9169-1","article-title":"Evaluation of mucoadhesive PLGA microparticles for nasal immunization","volume":"12","author":"Pawar","year":"2010","journal-title":"AAPS J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5173(92)90353-4","article-title":"In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers","volume":"78","author":"Lehr","year":"1992","journal-title":"Int. J. Pharm."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sarmento, B., and Neves, J. (2012). Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics, John Wiley & Sons, Ltd.","DOI":"10.1002\/9781119962977"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-0987(01)00172-5","article-title":"Chitosan and its derivatives in mucosal drug and vaccine delivery","volume":"14","author":"Verhoef","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/S0264-410X(03)00305-0","article-title":"The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines","volume":"21","author":"Baudner","year":"2003","journal-title":"Vaccine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1016\/j.vaccine.2012.06.035","article-title":"Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics","volume":"30","author":"Tafaghodia","year":"2012","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","article-title":"Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: Enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan","volume":"22","author":"McNeela","year":"2004","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","article-title":"N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model","volume":"25","author":"Amidi","year":"2007","journal-title":"Vaccine"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Jain, R., Dey, B., Dhar, N., Rao, V., Singh, R., Gupta, U.D., Katoch, V.M., Ramanathan, V.D., and Tyagi, A.K. (2008). Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003869"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1016\/j.vaccine.2011.09.033","article-title":"Development and characterization of chitosan coated poly-(\u03b5-caprolactone) nanoparticulate system for effective immunization against influenza","volume":"29","author":"Gupta","year":"2011","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2003.09.006","article-title":"Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice","volume":"57","author":"Vila","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biotechadv.2009.06.007","article-title":"Application of chitosan microspheres for nasal delivery of vaccines","volume":"27","author":"Kang","year":"2009","journal-title":"Biotechnol. Adv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpb.2012.07.005","article-title":"Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model","volume":"82","author":"Rodrigues","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1128\/IAI.72.2.1169-1173.2004","article-title":"Activated THP-1 cells: An attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates","volume":"72","author":"Theus","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: An in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/02652048.2012.700957","article-title":"Factorial design analysis and optimisation of alginate-Ca-chitosan microspheres","volume":"30","author":"Makraduli","year":"2013","journal-title":"J. Microencapsul."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1208\/s12249-010-9406-z","article-title":"Evaluation of chitosan\/alginate beads using experimental design: Formulation and in vitro characterization","volume":"11","author":"Takka","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2006.05.018","article-title":"Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity","volume":"40","author":"Kalkanidis","year":"2006","journal-title":"Methods"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jconrel.2009.10.032","article-title":"Nanosystem drug targeting: Facing up to complex realities","volume":"141","author":"Ruenraroengsak","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1080\/02652040601034013","article-title":"Stabilizing effects of calcium alginate microspheres on Mycobacterium bovis BCG intended for oral vaccination","volume":"23","author":"Dobakhti","year":"2006","journal-title":"J. Microencapsul."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1211\/jpp.58.6.0002","article-title":"Particulate delivery systems for vaccines: What can we expect?","volume":"58","author":"Bramwell","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrmicro2437","article-title":"Nanobead-based interventions for the treatment and prevention of tuberculosis","volume":"8","author":"Griffiths","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.addr.2004.09.008","article-title":"Immunity in response to particulate antigen-delivery systems","volume":"57","author":"Storni","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0169-409X(98)00045-3","article-title":"Microparticles and polymers for the mucosal delivery of vaccines","volume":"34","author":"Hagan","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0264-410X(02)00686-2","article-title":"Chitosan microparticles for mucosal vaccination against diphtheria: Oral and nasal efficacy studies in mice","volume":"21","author":"Kersten","year":"2003","journal-title":"Vaccine"},{"key":"ref_67","unstructured":"Garrity, G.M., Bell, J.A., Lilburn, T.G., and Lansing, E. (2004). Bergey\u2019s Manual of Systematic Bacteriology, Springer-Verlag."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1015954316139","article-title":"Size characterization of Mycobacterium bovic BCG (Bacillus Calmette Gu\u00e9rin) Vaccine, Tice Substrain","volume":"5","author":"Zhang","year":"1988","journal-title":"Pharm. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0955-0674(03)00083-8","article-title":"Phagocytosis: Latex leads the way","volume":"15","author":"Desjardins","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/app.11989","article-title":"Polyelectrolye complex formation between alginate and Chitosan as a function of pH","volume":"88","author":"Bond","year":"2003","journal-title":"J. Appl. Polym. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2004.02.002","article-title":"A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery","volume":"96","author":"Chen","year":"2004","journal-title":"J. Control. Release"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijpharm.2012.04.059","article-title":"Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations","volume":"431","author":"Kaasalainen","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_74","first-page":"191","article-title":"The surface charge of cells of Mycobacterium bovis BCG vaccine, Tice substrain","volume":"53","author":"Zhang","year":"1988","journal-title":"Microbios"},{"key":"ref_75","first-page":"529","article-title":"On the killing of mycobacteria by macrophages","volume":"10","author":"Jordao","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_76","unstructured":"M\u00e9ndez-Vilas, A., and D\u00edaz, J. (2010). Microscopy: Science, Technology, Applications and Education, FORMATEX."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.carbpol.2003.07.009","article-title":"Study on antimicrobial activity of chitosan with different molecular weights","volume":"54","author":"Zheng","year":"2003","journal-title":"Carbohydr. Polym."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.fm.2004.02.008","article-title":"Chitosan: Antimicrobial activity, interactions with food components and applicability as a coating on fruit and vegetables","volume":"21","author":"Devlieghere","year":"2004","journal-title":"Food Microbiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.carbpol.2005.10.028","article-title":"Effect of MW and concentration of chitosan on antibacterial activity of Escherichia coli","volume":"64","author":"Liu","year":"2006","journal-title":"Carbohydr. Polym."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1751-7915.2008.00080.x","article-title":"Chitosan and its antimicrobial potential\u2014A critical literature survey","volume":"2","author":"Raafat","year":"2009","journal-title":"Microb. Biotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S0104-14282009000300013","article-title":"A review of the antimicrobial activity of chitosan","volume":"19","author":"Goy","year":"2009","journal-title":"Pol\u00edm. Ci\u00eanc. Tecnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp.55.10.778","article-title":"The efficacy of the heat killing of Mycobacterium tuberculosis","volume":"55","author":"Doig","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0040-6031(02)00523-3","article-title":"Thermogravimetric and FTIR studies of chitosan blends","volume":"396","author":"Pawlak","year":"2003","journal-title":"Thermochim. Acta"}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/14\/5\/90\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:23:38Z","timestamp":1760210618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/14\/5\/90"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"alternative-id":["md14050090"],"URL":"https:\/\/doi.org\/10.3390\/md14050090","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]}}}